MD-7246

Ironwood Pharmaceuticals, Inc. · Phase 2 active Small molecule

At a glance

Generic name	MD-7246
Sponsor	Ironwood Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

MD-7246 CI brief — competitive landscape report
MD-7246 updates RSS · CI watch RSS
Ironwood Pharmaceuticals, Inc. portfolio CI